« O Neurocaster |
Main
| NIO Unveils Top 10 Neuroscience Trends for 2009 »
November 11, 2008
NIO CEO Media Tour in NYC Gets Results
Posted by Zack Lynch
Yesterday, I hosted NIO's annual public neurotech company CEO media tour here in NYC with Uli Hacksell, CEO of Acadia Pharmaceuticals, Ron Cohen, CEO of Acorda Therapeutics and Joern Aldag, CEO of Evotec joining me in hour long discussions with reporters at the Wall Street Journal, BusinessWeek, PharmaWire (Financial Times), Discover Magazine, and Forbes. The discussions were lively and revolved around the impact of the current financial crisis as well as the lack of adequate regulatory resources. The Wall Street Journal picked up on our conversation and posted some of it on the WSJ Health Blog: FDA Delays Take Toll on Neuroscience Drug Developmentposted by Shirley S. Wang.
"The FDA has even the neuroscience crowd scratching their heads.
Some folks from the Neurotechnology Industry Organization, a trade group for neuroscience companies, and three of its members stopped by Health Blog HQ today. Our chat really heated up when it turned to the current regulatory environment...(more)
Comments (0)
+ TrackBacks (0) | Category: Neurotech Industry
POST A COMMENT
Thanks for signing in,
.
Now you can comment. (sign out)
(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)
- RELATED ENTRIES
- › NIO Unveils Top 10 Neuroscience Trends for 2009
- › NIO CEO Media Tour in NYC Gets Results
- › O Neurocaster
- › Manuscript Sent to Japan
- › 2009 Stem Cell Trendsetters in Neurology and Psychiatry
- › Mental Health Parity Legislation Passes within Financial Package
- › Holy Neurofinancial Meltdown Bernanke
- › Interest in Neuropolicy Grows
Zack Lynch is author of 
